Introduction: The number of patients with pulmonary disease caused by non-tuberculous
mycobacteria (NTM) is increasing globally. Poor resistance against infections, for example …

The genus Mycobacterium comprises not only the deadliest of bacterial pathogens,
Mycobacterium tuberculosis, but several other pathogenic species, including M. avium and …

The prevalence of lung disease due to infections with nontuberculous mycobacteria (NTM)
has been increasing and surpassed tuberculosis (TB) in some countries. Treatment …

Nontuberculous mycobacteria: the changing epidemiology and t... : Current Opinion in
Pulmonary Medicine Nontuberculous mycobacteria: the changing epidemiology and …

Nontuberculous mycobacterial infections and colonization are becoming more prevalent
worldwide. Mycobacterium abscessus complex (MABC) is one of the predominant …

Nontuberculous mycobacteria (NTM) encompass more than 200 species of bacteria. Of
these, only a small number of species are known to cause human disease; most commonly …

Background The natural resistance of rapidly growing mycobacteria (RGM) to multiple
antibiotics renders the treatment of the infections caused less successful. The objective of …

Objective The objective of the research was to assess the susceptibility of the slowly growing
nontuberculous mycobacteria strains to the antimicrobial drugs used for mycobaterioses …

Objective To evaluate the effectiveness and safety of linezolid-containing regimens for
treatment of M. abscessus pulmonary disease. Methods The records of 336 patients with M …

Nontuberculous mycobacteria (NTM) are ubiquitous in the environment and cause a wide
range of diseases in humans. Pulmonary involvement, the most common disease …